Last reviewed · How we verify

NCT04506931

Comparison of SMS, IVR, and CATI Surveys in Colombia

Completed NA Last updated 26 April 2022
What this trial tests

NA trial testing SMS Survey in Surveys and Questionnaires in 5,676 participants. Completed in 30 April 2021.

Timeline
15 January 2021
Primary endpoint
30 April 2021
30 April 2021

Quick facts

Lead sponsorJohns Hopkins Bloomberg School of Public Health
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeother
Enrollment5,676
Start date15 January 2021
Primary completion30 April 2021
Estimated completion30 April 2021
Sites1 location across Colombia

Drugs / interventions tested

Conditions studied

Sponsor

Johns Hopkins Bloomberg School of Public Health

Who can join

18 and older, any sex, with Surveys and Questionnaires or Noncommunicable Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of the study is to adapt and assess the feasibility, quality, and validity of short message service or 'text message' (SMS), interactive voice response (IVR), and computer assisted telephone interviews (CATI) for collecting information on noncommunicable disease (NCD) risk factors

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Surveys and Questionnaires

Currently open trials in the same condition.

Other Johns Hopkins Bloomberg School of Public Health trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04506931.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing